Final answer:
Communicate to clients taking Aricept, a medication for Alzheimer's and Parkinson's dementia, that while it can manage symptoms, it is not a cure, and to be aware of potential side effects. They should take it consistently, watch for severe side effects, and have regular follow-ups with their healthcare provider.
Step-by-step explanation:
Rivastigmine, which is marketed under the brand name Aricept, is a medication prescribed for the treatment of mild to moderate dementia associated with Alzheimer's disease and Parkinson's disease. It is critical to communicate to the client that Aricept can help manage symptoms of cognitive decline but is not a cure for Alzheimer's disease. The goal of the medication is to improve cognition and behavior.
Patients should be made aware of possible side effects which may include nausea, vomiting, loss of appetite, and weight loss. They should also be advised to take the medication consistently and not abruptly stop the treatment as it may worsen symptoms. Monitoring for any allergic reactions or more severe side effects should be recommended. Lastly, it is important to have regular follow-ups with the healthcare provider to assess the effectiveness and tolerability of the medication.